β-hydroxybutyrate potentiates anti-tumor immunity by modulating cytotoxic CD8+ T cell responses
Cancer Immunology, Immunotherapy · 20.05.2026 · 75 (8)
DOI: 10.1007/s00262-026-04420-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 20.05.2026. Verfasst von Yupan Bai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, CD8-Positive T-Lymphocytes, T-Lymphocytes, Cytotoxic. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, the National Natural Science Foundation of China, The Innovative Research Team of High-level Local Universities in Shanghai.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
- Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200125, China.
- Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
- Department of Microbiology and Immunology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- Department of Infectious Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. xujie@shsmu.edu.cn.
- Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200125, China. huangjing@shsmu.edu.cn.
Förderung
- National Key Research and Development Program of China
- the National Natural Science Foundation of China
- The Innovative Research Team of High-level Local Universities in Shanghai
Zitieren
APA
Bai, Y., Xue, H., Bao, Y., Pan, Y., Tang, J., Wang, M., Wang, Y., Xu, J., & Huang, J. (2026). β-hydroxybutyrate potentiates anti-tumor immunity by modulating cytotoxic CD8+ T cell responses. Cancer Immunology, Immunotherapy, 75(8). https://doi.org/10.1007/s00262-026-04420-0
Vancouver
Bai Y, Xue H, Bao Y, Pan Y, Tang J, Wang M, et al. β-hydroxybutyrate potentiates anti-tumor immunity by modulating cytotoxic CD8+ T cell responses. Cancer Immunology, Immunotherapy. 2026;75(8). doi:10.1007/s00262-026-04420-0
BibTeX
@article{Bai2026,
author = {Bai, Yupan and Xue, Han and Bao, Yujie and Pan, Yue and Tang, Jiayin and Wang, Mengna and Wang, Ying and Xu, Jie and Huang, Jing},
title = {β-hydroxybutyrate potentiates anti-tumor immunity by modulating cytotoxic CD8+ T cell responses},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {8},
doi = {10.1007/s00262-026-04420-0}
}
EUVIMED